News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biotech Day In Review: Novartis International AG (NVS) Pulls Zelnorm Off The Market



4/2/2007 2:32:17 AM

Centient Biotech Investor submits: Novartis (NVS) suspended sales of Zelnorm, a treatment for irritable bowel syndrome with constipation, at the request of the FDA. The agency noticed a statistically significant number of cases of angina pectoris in patients taking the drug.

>>> Discuss This Story


Read at Seeking Alpha


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES